ProCE Banner Activity

CE / CME

Novel Molecular Targets in MDD

Multimedia
This webcast reviews molecular targets in MDD.

Psychologists: 1.00 APA CE Credit

Physicians : maximum of 1.00 AMA PRA Category 1 {Credit}

Pharmacists : 1.00 contact {hour} ({0.1} CEUs)

Physician Assistants : maximum of 1.00 {hour} of AAPA Category I (Preapproved) {credit}

Released: February 22, 2021

Expiration: February 22, 2022

No longer available for credit.

Share

Faculty

Maurizio Fava

Maurizio Fava, MD

Associate Dean for Clinical & Translational Research
Slater Family Professor of Psychiatry, Harvard Medical School

Provided by

Provided by Postgraduate Institute for Medicine
ProCE Banner

Supporters

This activity is supported by independent educational grants from

Neurocrine Biosciences

Sunovion

Target Audience

This activity is intended for physicians, physician assistants, nurse practitioners, registered nurses, pharmacists and psychologists engaged in the care of patients with mood disorders.

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Identify novel targets including glutamate, mTorc, for treating depression
  • Discuss medications that target these systems and show efficacy for major depression
  • Describe the potential advantages on novel compounds in major depression

Disclosure

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy.  PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

Faculty Disclosure

Primary Author

Maurizio Fava, MD

Associate Dean for Clinical & Translational Research
Slater Family Professor of Psychiatry, Harvard Medical School

Maurizio Fava, MD, has disclosed that he has received funds for research support from Acadia, Allergan, Alkermes, Aptinyx, Avanir, Axsome, Benckiser, BioClinica, Biogen, BioHaven, Cambridge Science Corporation, Cerecor, Gate Neurosciences, GenOmind, Gentelon, Happify, Johnson & Johnson, Lundbeck Marinus, Methylation Sciences, Millennium, Minerva Neurosciences, Neuralstem, NeuroRX, Novartis, Otsuka, Pfizer, Premiere Research International, Relmada, Reckitt, Shenox, Stanley Medical Research Institute, Taisho, Takeda, and Vistagen; stock/other financial options from Compellis; Psy Therapeutics; royalty/patent, other income from Patents for Sequential Parallel Comparison Design (SPCD), licensed by MGH to Pharmaceutical Product Development, LLC (PPD) (US_7840419, US_7647235, US_7983936, US_8145504, US_8145505); and patent application for a combination of Ketamine plus Scopolamine in Major Depressive Disorder (MDD), licensed by MGH to Biohaven; patents for pharmacogenomics of Depression Treatment with Folate (US_9546401, US_9540691); and copyright for the MGH Cognitive & Physical Functioning Questionnaire (CPFQ), Sexual Functioning Inventory (SFI), Antidepressant Treatment Response Questionnaire (ATRQ), Discontinuation-Emergent Signs & Symptoms (DESS), Symptoms of Depression Questionnaire (SDQ), and SAFER.

Instructions for Credit

Joint Accreditation Statement



In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Medical Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1 contact hour. Designated for 0.5 contact hour of pharmacotherapy credit for Advanced Practice Registered Nurses.

California Board of Registered Nursing
Provider approved by the California Board of Registered Nursing, Provider Number 13485, for 1 contact hour.

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number –JA4008162-9999-21-2592-H01-P

Type of Activity: Knowledge

AAPA Credit Designation Statement
This activity is designated for 1 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.

Continuing Psychologist Education
Continuing education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility of the program.

Credit Designation

This program offers 1.0 continuing education credit for psychologists.

Disclosure of Unlabeled Use

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

The Global Medical Education planner and manager, Prakash Masand, MD, has disclosed the following

Additional Information

Participation in this self-study activity should be completed in approximately 1 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from February 22, 2021, through February 22, 2022:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 70% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.